Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era.

Hardinger, K L; Stratta, R J; Egidi, M F; Alloway, R R; Shokouh-Amiri, M H; Gaber, L W; Grewal, H P; Honaker, M R; Vera, S; Gaber, A O

Hardinger, K L; Stratta, R J; Egidi, M F; Alloway, R R; Shokouh-Amiri, M H; Gaber, L W; Grewal, H P; Honaker, M R; Vera, S; Gaber, A O.

Affiliation

Hardinger KL; Department of Pharmacy, University of Tennessee-Memphis, 38163-2116, USA.

Surgery ; 130(4): 738-45; discussion 745-7, 2001 Oct.

Article in En | MEDLINE | ID: mdl-11602906

Subject(s)

Immunosuppressive Agents/therapeutic use; Kidney Transplantation; Tacrolimus/therapeutic use; Adult; Aged; Black People; Cyclosporine/therapeutic use; Female; Graft Rejection/epidemiology; Graft Survival; Humans; Kidney Diseases/etiology; Kidney Transplantation/adverse effects; Kidney Transplantation/mortality; Male; Middle Aged; Transplantation, Homologous; White People

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Tacrolimus / Immunosuppressive Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Surgery Year: 2001 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links